Cargando…

Healthcare pathway and patients' expectations in pulmonary fibrosis

Patients with pulmonary fibrosis want earlier referral to excellence centres and an improved network of care http://ow.ly/pidy30abNoH

Detalles Bibliográficos
Autores principales:	Cottin, Vincent, Bourdin, Arnaud, Crestani, Bruno, Prévot, Grégoire, Guérin, Marie, Bouquillon, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2017
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555763/ https://www.ncbi.nlm.nih.gov/pubmed/28828378 http://dx.doi.org/10.1183/23120541.00134-2016

Ejemplares similares

Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey
por: Cottin, Vincent, et al.
Publicado: (2015)

Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
por: Cottin, Vincent, et al.
Publicado: (2014)

NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer
por: Borie, Raphael, et al.
Publicado: (2021)

No association between human herpesvirus or herpesvirus saimiri and idiopathic pulmonary fibrosis
por: Le Hingrat, Quentin, et al.
Publicado: (2020)

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?
por: Sesé, Lucile, et al.
Publicado: (2021)

Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis
por: Froidure, Antoine, et al.
Publicado: (2020)

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response
por: Cottin, Vincent, et al.
Publicado: (2011)

Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis
por: Jouneau, Stéphane, et al.
Publicado: (2020)

Familial pulmonary fibrosis: a world without frontiers
por: Borie, Raphael, et al.
Publicado: (2019)

Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP)
por: Naccache, Jean-Marc, et al.
Publicado: (2019)

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension
por: Richeldi, Luca, et al.
Publicado: (2018)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

The role of pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent
Publicado: (2013)

Clinical case: Combined pulmonary fibrosis and emphysema with pulmonary hypertension – clinical management
por: Cottin, Vincent
Publicado: (2013)

Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison
por: Papiris, Spyros A., et al.
Publicado: (2019)

[(18)F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis
por: Justet, Aurélien, et al.
Publicado: (2017)

Criteria for Progressive Pulmonary Fibrosis: Getting the Horse Ready for the Cart
por: Cottin, Vincent
Publicado: (2022)

Physiology of the lung in idiopathic pulmonary fibrosis
por: Plantier, Laurent, et al.
Publicado: (2018)

Pilot experience of multidisciplinary team discussion dedicated to inherited pulmonary fibrosis
por: Borie, Raphael, et al.
Publicado: (2019)

Cough in idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2016)

Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
por: Kolb, Martin, et al.
Publicado: (2023)

Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey
por: Cottin, Vincent
Publicado: (2014)

Neglected evidence in idiopathic pulmonary fibrosis and the importance of early diagnosis and treatment
por: Cottin, Vincent, et al.
Publicado: (2014)

Transcriptome of Cultured Lung Fibroblasts in Idiopathic Pulmonary Fibrosis: Meta-Analysis of Publically Available Microarray Datasets Reveals Repression of Inflammation and Immunity Pathways
por: Plantier, Laurent, et al.
Publicado: (2016)

Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey
por: Lancaster, Lisa H., et al.
Publicado: (2020)

Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can't see the forest for the trees!
por: Castaldo, Alice, et al.
Publicado: (2023)

The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
por: Borie, Raphael, et al.
Publicado: (2013)

Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden
por: Lancaster, Lisa, et al.
Publicado: (2021)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
por: Podolanczuk, Anna J., et al.
Publicado: (2023)

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent, et al.
Publicado: (2015)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Morphologic and molecular study of lung cancers associated with idiopathic pulmonary fibrosis and other pulmonary fibroses
por: Guyard, Alice, et al.
Publicado: (2017)

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2017)

Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis
por: Borie, Raphael, et al.
Publicado: (2013)

Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
por: Zhao, An, et al.
Publicado: (2021)

A solitary bronchial papilloma with unusual endoscopic presentation: case study and literature review
por: Paganin, Fabrice, et al.
Publicado: (2009)

Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review
por: Luppi, Fabrizio, et al.
Publicado: (2015)

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials
por: Costabel, Ulrich, et al.
Publicado: (2018)

Progressive Pulmonary Fibrosis: Should the Timelines Be Taken Out of the Definition?
por: Cottin, Vincent, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_af72no5ji53unmqtqr2ons673t